Us Bancorp \De\ Boston Scientific Corp Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Boston Scientific Corp stock. As of the latest transaction made, Us Bancorp \De\ holds 354,392 shares of BSX stock, worth $31.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

354,392

Previous 360,508 1.7%

Holding current value

$31.9 Million

Previous $27.8 Million 6.97%

% of portfolio

0.04%

Previous 0.04%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$72.96 - $84.0 $446,223 - $513,744	-6,116 Reduced 1.7%	354,392 $29.7 Million
Q2 2024 Aug 06, 2024	SELL	$67.33 - $77.71 $129,071 - $148,970	-1,917 Reduced 0.53%	360,508 $27.8 Million
Q1 2024 May 07, 2024	SELL	$57.6 - $68.62 $820,684 - $977,697	-14,248 Reduced 3.78%	362,425 $24.8 Million
Q4 2023 Feb 09, 2024	SELL	$48.64 - $57.81 $3.26 Million - $3.88 Million	-67,064 Reduced 15.11%	376,673 $21.8 Million
Q3 2023 Nov 03, 2023	BUY	$50.19 - $54.68 $584,261 - $636,529	11,641 Added 2.69%	443,737 $23.4 Million
Q2 2023 Aug 09, 2023	SELL	$49.72 - $54.64 $728,447 - $800,530	-14,651 Reduced 3.28%	432,096 $23.4 Million
Q1 2023 May 09, 2023	SELL	$45.09 - $50.03 $462,037 - $512,657	-10,247 Reduced 2.24%	446,747 $22.4 Million
Q4 2022 Feb 13, 2023	BUY	$39.56 - $47.22 $9.96 Million - $11.9 Million	251,715 Added 122.62%	456,994 $21.1 Million
Q3 2022 Oct 27, 2022	SELL	$36.71 - $109.66 $606,339 - $1.81 Million	-16,517 Reduced 7.45%	205,279 $7.95 Million
Q2 2022 Aug 01, 2022	SELL	$35.24 - $47.1 $172,323 - $230,319	-4,890 Reduced 2.16%	221,796 $8.27 Million
Q1 2022 May 11, 2022	BUY	$40.9 - $45.1 $96,605 - $106,526	2,362 Added 1.05%	226,686 $10 Million
Q4 2021 Feb 11, 2022	SELL	$38.07 - $44.87 $88,246 - $104,008	-2,318 Reduced 1.02%	224,324 $9.53 Million
Q3 2021 Nov 10, 2021	SELL	$41.23 - $45.88 $132,142 - $147,045	-3,205 Reduced 1.39%	226,642 $9.84 Million
Q2 2021 Aug 05, 2021	SELL	$38.58 - $44.24 $180,863 - $207,397	-4,688 Reduced 2.0%	229,847 $9.83 Million
Q1 2021 Apr 28, 2021	SELL	$35.27 - $39.67 $758,904 - $853,579	-21,517 Reduced 8.4%	234,535 $9.06 Million
Q4 2020 Feb 04, 2021	SELL	$33.15 - $41.97 $3.69 Million - $4.67 Million	-111,232 Reduced 30.29%	256,052 $9.21 Million
Q3 2020 Nov 10, 2020	BUY	$34.44 - $42.23 $201,405 - $246,961	5,848 Added 1.62%	367,284 $14 Million
Q2 2020 Aug 07, 2020	SELL	$30.19 - $39.11 $301,386 - $390,435	-9,983 Reduced 2.69%	361,436 $12.7 Million
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $122,873 - $217,442	-4,757 Reduced 1.26%	371,419 $12.1 Million
Q4 2019 Feb 04, 2020	BUY	$37.87 - $45.37 $960,193 - $1.15 Million	25,355 Added 7.23%	376,176 $17 Million
Q3 2019 Nov 08, 2019	BUY	$40.31 - $43.45 $333,968 - $359,983	8,285 Added 2.42%	350,821 $14.3 Million
Q2 2019 Aug 13, 2019	BUY	$34.91 - $42.98 $325,186 - $400,358	9,315 Added 2.8%	342,536 $14.7 Million
Q1 2019 May 08, 2019	SELL	$32.91 - $40.75 $55,058 - $68,174	-1,673 Reduced 0.5%	333,221 $12.8 Million
Q4 2018 Feb 13, 2019	BUY	$31.73 - $39.04 $298,611 - $367,405	9,411 Added 2.89%	334,894 $11.8 Million
Q3 2018 Nov 01, 2018	SELL	$32.83 - $38.63 $33,486 - $39,402	-1,020 Reduced 0.31%	325,483 $12.5 Million
Q2 2018 Aug 08, 2018	BUY	$26.84 - $34.32 $705,865 - $902,581	26,299 Added 8.76%	326,503 $10.7 Million
Q1 2018 May 08, 2018	SELL	$25.2 - $28.54 $306,104 - $346,675	-12,147 Reduced 3.89%	300,204 $8.2 Million
Q4 2017 Feb 02, 2018	SELL	$24.79 - $29.8 $1.56 Million - $1.88 Million	-63,076 Reduced 16.8%	312,351 $7.74 Million
Q3 2017 Nov 13, 2017	BUY	$26.26 - $29.17 $9.86 Million - $11 Million	375,427	375,427 $11 Million

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account